Company: UPC
Filing Date: 2025-03-11
Form Type: 6-K
Source: 0001213900-25-022737
Chunk: 2

Company: Universe Pharmaceuticals INC
Filing Date: 2025-03-11
Form: 6-K
Chunk 2
---
588 |
| Percentage of Voted Shares: |     |     |   89.41 | % |     |         |   10.59 | % |     |         |       |

| 1. | It is resolved as a special resolution, that subject to and immediately following the Share Consolidation being effected, the Company adopt an amended and restated memorandum of association in substitution for, and to the exclusion of, the Company’s then existing memorandum of association, to reflect the Share Consolidation (the “Proposal Two”). |

| Resolution                  |     | For |         |   |     | Against |         |   |     | Abstain |       |
| Proposal Two                |     |     | 985,234 |   |     |         | 116,663 |   |     |         | 1,824 |
| Percentage of Voted Shares: |     |     |   89.41 | % |     |         |   10.59 | % |     |         |       |

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

| Date: March 11, 2025 | Universe Pharmaceuticals INC. 
 By:                           | /s/ Gang Lai            |
|:---------------------|:------------------------------|:------------------------|
|                      |                               | Gang Lai                |
|                      |                               | Chief Executive Officer |

<div align='center'>2</div>